All Drugs Associated with Malignant neoplasm progression (Page 5)
771 drugs have been associated with Malignant neoplasm progression in FAERS reports.
| Drug | Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|
| LOMUSTINE | 62 | 16 | 12 | 2 |
| MITOTANE | 61 | 15 | 14 | 5 |
| OFATUMUMAB | 61 | 29 | 20 | 5 |
| GLIVEC | 60 | 53 | 12 | 1 |
| YERVOY | 59 | 26 | 20 | 5 |
| CHOLECALCIFEROL | 58 | 4 | 45 | 2 |
| PIPERACILLIN\TAZOBACTAM | 58 | 42 | 49 | 14 |
| BLINATUMOMAB | 57 | 10 | 32 | 3 |
| DAUNORUBICIN | 57 | 17 | 7 | 2 |
| ENOXAPARIN | 57 | 43 | 18 | 6 |
| VALSARTAN | 57 | 22 | 29 | 7 |
| DECITABINE | 56 | 15 | 15 | 2 |
| LOSARTAN | 56 | 12 | 33 | 9 |
| BISOPROLOL | 55 | 22 | 27 | 7 |
| BUSULFAN | 55 | 9 | 5 | 0 |
| ZOLBETUXIMAB-CLZB | 55 | 14 | 9 | 0 |
| LANSOPRAZOLE | 54 | 18 | 40 | 9 |
| NECITUMUMAB | 54 | 19 | 16 | 3 |
| FLUOROURACIL\LEUCOVORIN\OXALIPLATIN | 53 | 11 | 12 | 2 |
| LEVOTHYROXINE | 53 | 10 | 16 | 4 |
| SIROLIMUS | 53 | 25 | 6 | 2 |
| ESOMEPRAZOLE | 52 | 24 | 15 | 2 |
| THIOTEPA | 52 | 30 | 11 | 2 |
| ATENOLOL | 51 | 7 | 42 | 1 |
| CODEINE | 50 | 15 | 27 | 10 |
| IBANDRONIC ACID | 50 | 3 | 4 | 1 |
| LISINOPRIL | 50 | 17 | 18 | 3 |
| TIVOZANIB | 50 | 9 | 13 | 1 |
| FOLIC ACID | 48 | 17 | 24 | 2 |
| RIVAROXABAN | 48 | 17 | 25 | 4 |
| BOSUTINIB | 47 | 4 | 6 | 0 |
| NERATINIB | 47 | 4 | 16 | 0 |
| SITAGLIPTIN | 47 | 26 | 26 | 8 |
| TAFASITAMAB | 47 | 17 | 12 | 4 |
| VANDETANIB | 47 | 5 | 29 | 1 |
| ALLOPURINOL | 45 | 11 | 30 | 5 |
| ROMIDEPSIN | 45 | 17 | 8 | 1 |
| SANDOSTATIN LAR | 45 | 30 | 20 | 1 |
| TAMSULOSIN | 45 | 3 | 26 | 1 |
| VORINOSTAT | 45 | 13 | 6 | 0 |
| XELODA | 45 | 8 | 7 | 0 |
| AREDIA | 44 | 21 | 32 | 1 |
| DEGARELIX | 44 | 8 | 13 | 3 |
| GRANULOCYTE COLONY-STIMULATING FACTOR NOS | 43 | 25 | 6 | 1 |
| METHADONE | 43 | 25 | 20 | 3 |
| OLARATUMAB | 43 | 10 | 8 | 12 |
| PIRTOBRUTINIB | 43 | 33 | 23 | 3 |
| POTASSIUM, DIBASIC | 43 | 0 | 0 | 0 |
| VANCOMYCIN | 41 | 18 | 27 | 4 |
| APALUTAMIDE | 40 | 4 | 3 | 0 |